| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 6.45e-07 | 276 | 37 | 7 | GO:0003730 | |
| GeneOntologyMolecularFunction | mRNA binding | 3.65e-06 | 694 | 37 | 9 | GO:0003729 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.05e-04 | 78 | 37 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 4.36e-04 | 80 | 37 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 9.76e-04 | 25 | 37 | 2 | GO:0048027 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 1.31e-03 | 29 | 37 | 2 | GO:0035925 | |
| GeneOntologyBiologicalProcess | RNA splicing | RBM6 ZNF326 FAM98A TAF15 FUS DDX17 HNRNPUL1 HNRNPA1L3 RBM3 HNRNPH3 | 1.71e-08 | 502 | 38 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | RBM6 NANOS3 DHX36 ZNF326 TAF15 FUS DDX17 HNRNPUL1 PUM1 HNRNPA1L3 RBM3 HNRNPH3 | 5.15e-08 | 917 | 38 | 12 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA processing | RBM6 DHX36 ZNF326 FAM98A TAF15 FUS DDX17 HNRNPUL1 PUM1 HNRNPA1L3 RBM3 HNRNPH3 DDX3X | 1.46e-06 | 1500 | 38 | 13 | GO:0006396 |
| GeneOntologyBiologicalProcess | mRNA processing | 5.95e-06 | 551 | 38 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.43e-05 | 443 | 38 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 3.72e-05 | 207 | 38 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.53e-05 | 358 | 38 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.53e-05 | 358 | 38 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.82e-05 | 362 | 38 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | miRNA processing | 9.42e-05 | 48 | 38 | 3 | GO:0035196 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 1.18e-04 | 9 | 38 | 2 | GO:0010501 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.88e-04 | 292 | 38 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | negative regulation of dendrite morphogenesis | 2.16e-04 | 12 | 38 | 2 | GO:0050774 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 2.41e-04 | 308 | 38 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 2.44e-04 | 309 | 38 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of translation | 2.64e-04 | 494 | 38 | 6 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 3.42e-04 | 74 | 38 | 3 | GO:0070918 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.90e-04 | 16 | 38 | 2 | GO:1900153 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 4.71e-04 | 198 | 38 | 4 | GO:0048813 | |
| GeneOntologyBiologicalProcess | cellular response to arsenic-containing substance | 5.54e-04 | 19 | 38 | 2 | GO:0071243 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA destabilization | 5.54e-04 | 19 | 38 | 2 | GO:0061158 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 5.68e-04 | 88 | 38 | 3 | GO:0043489 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 5.79e-04 | 373 | 38 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 7.90e-04 | 846 | 38 | 7 | GO:0120035 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 8.01e-04 | 99 | 38 | 3 | GO:0045104 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 8.19e-04 | 612 | 38 | 6 | GO:0010975 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 8.25e-04 | 100 | 38 | 3 | GO:0045103 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 8.26e-04 | 230 | 38 | 4 | GO:0017148 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 8.49e-04 | 101 | 38 | 3 | GO:1902369 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 8.88e-04 | 863 | 38 | 7 | GO:0031344 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 8.99e-04 | 103 | 38 | 3 | GO:0048814 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.01e-03 | 1153 | 38 | 8 | GO:0010608 | |
| GeneOntologyBiologicalProcess | response to virus | 1.04e-03 | 425 | 38 | 5 | GO:0009615 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.12e-03 | 432 | 38 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.13e-03 | 27 | 38 | 2 | GO:1900151 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.28e-03 | 259 | 38 | 4 | GO:1903313 | |
| GeneOntologyBiologicalProcess | positive regulation of interferon-alpha production | 1.39e-03 | 30 | 38 | 2 | GO:0032727 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.53e-03 | 464 | 38 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 2.00e-03 | 36 | 38 | 2 | GO:0034063 | |
| GeneOntologyBiologicalProcess | response to arsenic-containing substance | 2.11e-03 | 37 | 38 | 2 | GO:0046685 | |
| GeneOntologyBiologicalProcess | regulation of interferon-alpha production | 2.11e-03 | 37 | 38 | 2 | GO:0032647 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 7.13e-07 | 96 | 37 | 5 | GO:0010494 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.06e-04 | 269 | 37 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.43e-04 | 287 | 37 | 5 | GO:0035770 | |
| Domain | Spectrin/alpha-actinin | 3.41e-05 | 32 | 37 | 3 | IPR018159 | |
| Domain | SPEC | 3.41e-05 | 32 | 37 | 3 | SM00150 | |
| Domain | RRM | 6.51e-05 | 217 | 37 | 5 | SM00360 | |
| Domain | RRM_dom | 8.06e-05 | 227 | 37 | 5 | IPR000504 | |
| Domain | RRM | 8.57e-05 | 230 | 37 | 5 | PS50102 | |
| Domain | - | 1.13e-04 | 244 | 37 | 5 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.47e-04 | 258 | 37 | 5 | IPR012677 | |
| Domain | - | 1.70e-04 | 10 | 37 | 2 | 4.10.1060.10 | |
| Domain | DEAD | 4.05e-04 | 73 | 37 | 3 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.05e-04 | 73 | 37 | 3 | IPR011545 | |
| Domain | RRM_1 | 7.40e-04 | 208 | 37 | 4 | PF00076 | |
| Domain | zf-RanBP | 8.60e-04 | 22 | 37 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 9.41e-04 | 23 | 37 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 9.41e-04 | 23 | 37 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 1.03e-03 | 24 | 37 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 1.11e-03 | 25 | 37 | 2 | IPR001876 | |
| Domain | Helicase_C | 1.23e-03 | 107 | 37 | 3 | PF00271 | |
| Domain | HELICc | 1.23e-03 | 107 | 37 | 3 | SM00490 | |
| Domain | Helicase_C | 1.27e-03 | 108 | 37 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 1.30e-03 | 109 | 37 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.30e-03 | 109 | 37 | 3 | PS51192 | |
| Domain | DEXDc | 1.30e-03 | 109 | 37 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.33e-03 | 110 | 37 | 3 | IPR014001 | |
| Domain | Spectrin_repeat | 1.50e-03 | 29 | 37 | 2 | IPR002017 | |
| Domain | DEAD_ATP_HELICASE | 1.71e-03 | 31 | 37 | 2 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 1.94e-03 | 33 | 37 | 2 | IPR000629 | |
| Domain | RNA_helicase_DEAD_Q_motif | 2.43e-03 | 37 | 37 | 2 | IPR014014 | |
| Domain | Q_MOTIF | 2.43e-03 | 37 | 37 | 2 | PS51195 | |
| Domain | Keratin_I | 3.43e-03 | 44 | 37 | 2 | IPR002957 | |
| Domain | Homeodomain-like | 4.08e-03 | 332 | 37 | 4 | IPR009057 | |
| Domain | Homeobox_CS | 5.89e-03 | 186 | 37 | 3 | IPR017970 | |
| Domain | Intermediate_filament_CS | 6.91e-03 | 63 | 37 | 2 | IPR018039 | |
| Domain | - | 7.24e-03 | 391 | 37 | 4 | 2.30.29.30 | |
| Domain | Filament | 8.71e-03 | 71 | 37 | 2 | SM01391 | |
| Domain | IF | 8.95e-03 | 72 | 37 | 2 | PS00226 | |
| Domain | Filament | 9.19e-03 | 73 | 37 | 2 | PF00038 | |
| Domain | PH_dom-like | 9.73e-03 | 426 | 37 | 4 | IPR011993 | |
| Domain | IF | 9.93e-03 | 76 | 37 | 2 | IPR001664 | |
| Domain | Homeobox | 1.10e-02 | 234 | 37 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.13e-02 | 236 | 37 | 3 | PS00027 | |
| Domain | HOX | 1.14e-02 | 237 | 37 | 3 | SM00389 | |
| Domain | Homeobox_dom | 1.17e-02 | 239 | 37 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.17e-02 | 239 | 37 | 3 | PS50071 | |
| Pathway | WP_MRNA_PROCESSING | 1.67e-05 | 451 | 27 | 7 | MM15946 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RBM6 DHX36 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C HNRNPH3 DDX3X | 6.78e-14 | 807 | 38 | 14 | 22681889 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.67e-13 | 258 | 38 | 10 | 37794589 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | DHX36 KRT9 ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C DDX3X | 1.81e-13 | 678 | 38 | 13 | 30209976 |
| Pubmed | 3.04e-13 | 274 | 38 | 10 | 34244482 | ||
| Pubmed | DHX36 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C HNRNPH3 DDX3X | 3.43e-13 | 713 | 38 | 13 | 29802200 | |
| Pubmed | ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PRRC2C KRT77 HNRNPH3 DDX3X | 4.13e-13 | 551 | 38 | 12 | 34728620 | |
| Pubmed | DHX36 KRT9 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C HNRNPH3 DDX3X | 4.23e-13 | 725 | 38 | 13 | 27025967 | |
| Pubmed | DHX36 KRT9 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 HNRNPH3 DDX3X | 6.44e-13 | 421 | 38 | 11 | 34650049 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBM6 ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C HNRNPH3 DDX3X | 6.52e-13 | 954 | 38 | 14 | 36373674 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | KRT9 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 RBM3 HNRNPH3 DDX3X | 8.10e-13 | 430 | 38 | 11 | 38172120 |
| Pubmed | 7.24e-12 | 90 | 38 | 7 | 23151878 | ||
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 8.87e-12 | 45 | 38 | 6 | 25496916 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT9 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 PRRC2C KRT77 HNRNPH3 DDX3X | 3.17e-11 | 605 | 38 | 11 | 28977666 |
| Pubmed | 4.96e-11 | 24 | 38 | 5 | 27507811 | ||
| Pubmed | 1.09e-10 | 346 | 38 | 9 | 25324306 | ||
| Pubmed | 2.13e-10 | 244 | 38 | 8 | 29884807 | ||
| Pubmed | 2.20e-10 | 245 | 38 | 8 | 35652658 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 2.93e-10 | 254 | 38 | 8 | 28431233 | |
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 3.58e-10 | 156 | 38 | 7 | 26170170 | |
| Pubmed | 1.03e-09 | 298 | 38 | 8 | 30737378 | ||
| Pubmed | 1.27e-09 | 187 | 38 | 7 | 29777862 | ||
| Pubmed | DHX36 KRT9 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 RBM3 KRT77 HNRNPH3 DDX3X | 2.03e-09 | 1153 | 38 | 12 | 29845934 | |
| Pubmed | 2.10e-09 | 109 | 38 | 6 | 29511296 | ||
| Pubmed | 2.18e-09 | 202 | 38 | 7 | 24639526 | ||
| Pubmed | 2.35e-09 | 491 | 38 | 9 | 22623428 | ||
| Pubmed | 2.48e-09 | 494 | 38 | 9 | 26831064 | ||
| Pubmed | 2.75e-09 | 114 | 38 | 6 | 31553912 | ||
| Pubmed | 4.32e-09 | 223 | 38 | 7 | 20020773 | ||
| Pubmed | ZNF326 FAM98A IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C HNRNPH3 | 4.40e-09 | 731 | 38 | 10 | 29298432 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RBM6 DHX36 ZNF326 TAF15 FUS ILF3 DDX17 HNRNPUL1 RBM3 HNRNPH3 DDX3X | 5.54e-09 | 989 | 38 | 11 | 36424410 |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 7.52e-09 | 384 | 38 | 8 | 31059266 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZNF326 TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 KRT77 HNRNPH3 DDX3X | 7.94e-09 | 1024 | 38 | 11 | 24711643 |
| Pubmed | 7.97e-09 | 136 | 38 | 6 | 21280222 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 KRT9 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 HNRNPH3 DDX3X | 9.06e-09 | 1318 | 38 | 12 | 30463901 |
| Pubmed | 1.06e-08 | 23 | 38 | 4 | 18320585 | ||
| Pubmed | 1.25e-08 | 260 | 38 | 7 | 36199071 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 1.27e-08 | 147 | 38 | 6 | 28977470 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RBM6 DHX36 KRT9 ZNF326 TAF15 GPC2 ILF3 DDX17 HNRNPUL1 HNRNPH3 DDX3X | 1.40e-08 | 1082 | 38 | 11 | 38697112 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 ZNF326 IRS4 FUS ILF3 DDX17 HNRNPUL1 BSN PUM1 TRIO HNRNPH3 DDX3X | 2.15e-08 | 1425 | 38 | 12 | 30948266 |
| Pubmed | 2.20e-08 | 441 | 38 | 8 | 31239290 | ||
| Pubmed | 2.58e-08 | 289 | 38 | 7 | 37132043 | ||
| Pubmed | 2.72e-08 | 652 | 38 | 9 | 31180492 | ||
| Pubmed | 2.83e-08 | 655 | 38 | 9 | 35819319 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.15e-08 | 462 | 38 | 8 | 31138677 | |
| Pubmed | 3.25e-08 | 172 | 38 | 6 | 26336360 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 3.25e-08 | 30 | 38 | 4 | 15782174 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | KRT9 FAM98A IRS4 DDX17 HNRNPUL1 PUM1 TRIO HNRNPH3 DDX3X PLCL2 | 3.94e-08 | 922 | 38 | 10 | 27609421 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 4.11e-08 | 179 | 38 | 6 | 36261009 | |
| Pubmed | 4.87e-08 | 90 | 38 | 5 | 33087562 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 5.90e-08 | 714 | 38 | 9 | 28302793 | |
| Pubmed | 6.37e-08 | 330 | 38 | 7 | 32529326 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DHX36 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 HNRNPH3 DDX3X | 6.45e-08 | 1257 | 38 | 11 | 37317656 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 KRT9 ZNF326 FUS ILF3 DDX17 HNRNPUL1 PRRC2C KRT77 HNRNPH3 DDX3X | 6.45e-08 | 1257 | 38 | 11 | 36526897 |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 7.20e-08 | 336 | 38 | 7 | 31253590 | |
| Pubmed | 7.80e-08 | 340 | 38 | 7 | 24332808 | ||
| Pubmed | 9.46e-08 | 206 | 38 | 6 | 22174317 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 1.02e-07 | 1021 | 38 | 10 | 26760575 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 1.08e-07 | 40 | 38 | 4 | 23825951 | |
| Pubmed | DHX36 ZNF326 FAM98A IRS4 FUS ILF3 DDX17 HNRNPUL1 PRRC2C HNRNPH3 DDX3X | 1.18e-07 | 1335 | 38 | 11 | 29229926 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 1.34e-07 | 558 | 38 | 8 | 27591049 | |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.74e-07 | 116 | 38 | 5 | 22810585 | |
| Pubmed | 1.75e-07 | 45 | 38 | 4 | 30619335 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.91e-07 | 232 | 38 | 6 | 25515538 | |
| Pubmed | 1.91e-07 | 46 | 38 | 4 | 20890123 | ||
| Pubmed | 1.97e-07 | 11 | 38 | 3 | 33469008 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DHX36 KRT9 FAM98A FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C HNRNPH3 DDX3X | 2.12e-07 | 1415 | 38 | 11 | 28515276 |
| Pubmed | 2.24e-07 | 122 | 38 | 5 | 29530978 | ||
| Pubmed | RBM6 DHX36 TCF4 ZNF326 IRS4 HNRNPUL1 PUM1 NFATC4 PRRC2C HNRNPH3 TLX2 | 2.34e-07 | 1429 | 38 | 11 | 35140242 | |
| Pubmed | 2.50e-07 | 847 | 38 | 9 | 35850772 | ||
| Pubmed | 2.80e-07 | 615 | 38 | 8 | 31048545 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.87e-07 | 861 | 38 | 9 | 36931259 | |
| Pubmed | 3.20e-07 | 419 | 38 | 7 | 15635413 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 3.40e-07 | 256 | 38 | 6 | 32698014 | |
| Pubmed | Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. | 3.42e-07 | 13 | 38 | 3 | 17765891 | |
| Pubmed | 3.53e-07 | 425 | 38 | 7 | 21081503 | ||
| Pubmed | 3.69e-07 | 638 | 38 | 8 | 33239621 | ||
| Pubmed | 3.83e-07 | 641 | 38 | 8 | 36057605 | ||
| Pubmed | 3.84e-07 | 136 | 38 | 5 | 26979993 | ||
| Pubmed | 4.13e-07 | 138 | 38 | 5 | 30320910 | ||
| Pubmed | 4.40e-07 | 653 | 38 | 8 | 33742100 | ||
| Pubmed | 4.40e-07 | 653 | 38 | 8 | 22586326 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 4.44e-07 | 268 | 38 | 6 | 33024031 | |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 4.59e-07 | 57 | 38 | 4 | 17932509 | |
| Pubmed | 4.74e-07 | 271 | 38 | 6 | 26816005 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 6.11e-07 | 283 | 38 | 6 | 28533407 | |
| Pubmed | 6.49e-07 | 286 | 38 | 6 | 32041737 | ||
| Pubmed | 6.89e-07 | 153 | 38 | 5 | 28225217 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 7.75e-07 | 704 | 38 | 8 | 32994395 | |
| Pubmed | 7.82e-07 | 971 | 38 | 9 | 33306668 | ||
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 7.96e-07 | 480 | 38 | 7 | 25437307 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 8.65e-07 | 486 | 38 | 7 | 30940648 | |
| Pubmed | 8.89e-07 | 488 | 38 | 7 | 31324722 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.03e-06 | 166 | 38 | 5 | 35687106 | |
| Pubmed | Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. | 1.16e-06 | 2 | 38 | 2 | 9795213 | |
| Pubmed | DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner. | 1.16e-06 | 2 | 38 | 2 | 34061233 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.27e-06 | 321 | 38 | 6 | 32098917 | |
| Pubmed | 1.29e-06 | 754 | 38 | 8 | 35906200 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.36e-06 | 759 | 38 | 8 | 35915203 | |
| Pubmed | 1.60e-06 | 334 | 38 | 6 | 30425250 | ||
| Pubmed | 1.90e-06 | 81 | 38 | 4 | 24965446 | ||
| Interaction | MYCN interactions | RBM6 DHX36 TCF4 KRT9 ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C KRT77 HNRNPH3 DDX3X TLX2 | 4.56e-12 | 1373 | 37 | 18 | int:MYCN |
| Interaction | RC3H2 interactions | DHX36 KRT9 ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C DDX3X | 4.99e-12 | 667 | 37 | 14 | int:RC3H2 |
| Interaction | MIRLET7D interactions | 1.03e-11 | 101 | 37 | 8 | int:MIRLET7D | |
| Interaction | SNRPA interactions | RBM6 ZNF326 TAF15 FUS ILF3 DDX17 LTK HNRNPUL1 RBM3 PRRC2C HNRNPH3 DDX3X | 3.29e-11 | 482 | 37 | 12 | int:SNRPA |
| Interaction | MIRLET7G interactions | 3.40e-11 | 117 | 37 | 8 | int:MIRLET7G | |
| Interaction | MIR138-1 interactions | 3.44e-11 | 68 | 37 | 7 | int:MIR138-1 | |
| Interaction | DCUN1D1 interactions | KRT9 ZNF326 TAF15 FUS ILF3 HNRNPUL1 RBM3 KRT77 HNRNPH3 DDX3X | 4.79e-11 | 275 | 37 | 10 | int:DCUN1D1 |
| Interaction | MIR20A interactions | 6.34e-11 | 74 | 37 | 7 | int:MIR20A | |
| Interaction | MIR199A2 interactions | 7.69e-11 | 76 | 37 | 7 | int:MIR199A2 | |
| Interaction | MIR200A interactions | 8.44e-11 | 77 | 37 | 7 | int:MIR200A | |
| Interaction | MIR98 interactions | 9.26e-11 | 78 | 37 | 7 | int:MIR98 | |
| Interaction | MIR1-2 interactions | 1.02e-10 | 79 | 37 | 7 | int:MIR1-2 | |
| Interaction | RC3H1 interactions | DHX36 KRT9 ZNF326 FAM98A IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C DDX3X | 1.05e-10 | 677 | 37 | 13 | int:RC3H1 |
| Interaction | MIR143 interactions | 1.11e-10 | 80 | 37 | 7 | int:MIR143 | |
| Interaction | MIR145 interactions | 1.21e-10 | 81 | 37 | 7 | int:MIR145 | |
| Interaction | MIR106A interactions | 1.45e-10 | 83 | 37 | 7 | int:MIR106A | |
| Interaction | MIR199A1 interactions | 1.58e-10 | 84 | 37 | 7 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 1.58e-10 | 84 | 37 | 7 | int:MIR200B | |
| Interaction | MIR107 interactions | 1.72e-10 | 85 | 37 | 7 | int:MIR107 | |
| Interaction | MIR17 interactions | 1.72e-10 | 85 | 37 | 7 | int:MIR17 | |
| Interaction | MIR18B interactions | 1.72e-10 | 85 | 37 | 7 | int:MIR18B | |
| Interaction | MIR93 interactions | 1.72e-10 | 85 | 37 | 7 | int:MIR93 | |
| Interaction | MIR20B interactions | 1.86e-10 | 86 | 37 | 7 | int:MIR20B | |
| Interaction | MIR29A interactions | 2.03e-10 | 87 | 37 | 7 | int:MIR29A | |
| Interaction | GLDC interactions | 2.18e-10 | 321 | 37 | 10 | int:GLDC | |
| Interaction | MIR29C interactions | 2.38e-10 | 89 | 37 | 7 | int:MIR29C | |
| Interaction | MIR92A2 interactions | 2.58e-10 | 90 | 37 | 7 | int:MIR92A2 | |
| Interaction | MIR214 interactions | 3.26e-10 | 93 | 37 | 7 | int:MIR214 | |
| Interaction | TRIM31 interactions | DHX36 KRT9 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 HNRNPH3 DDX3X | 3.39e-10 | 454 | 37 | 11 | int:TRIM31 |
| Interaction | MIR19B2 interactions | 3.52e-10 | 94 | 37 | 7 | int:MIR19B2 | |
| Interaction | PRMT1 interactions | ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C KRT77 HNRNPH3 DDX3X | 4.02e-10 | 929 | 37 | 14 | int:PRMT1 |
| Interaction | MIRLET7A2 interactions | 4.08e-10 | 96 | 37 | 7 | int:MIRLET7A2 | |
| Interaction | MIR21 interactions | 4.39e-10 | 97 | 37 | 7 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 4.39e-10 | 97 | 37 | 7 | int:MIRLET7F2 | |
| Interaction | MIR128-2 interactions | 5.08e-10 | 99 | 37 | 7 | int:MIR128-2 | |
| Interaction | MIR25 interactions | 5.85e-10 | 101 | 37 | 7 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 6.28e-10 | 102 | 37 | 7 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 6.73e-10 | 103 | 37 | 7 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 6.73e-10 | 103 | 37 | 7 | int:MIR7-1 | |
| Interaction | MIR19B1 interactions | 7.20e-10 | 104 | 37 | 7 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 7.20e-10 | 104 | 37 | 7 | int:MIR34A | |
| Interaction | MIRLET7E interactions | 8.24e-10 | 106 | 37 | 7 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 9.40e-10 | 108 | 37 | 7 | int:MIRLET7A1 | |
| Interaction | DDX3X interactions | DHX36 KRT9 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 PRRC2C KRT77 DDX3X | 1.03e-09 | 651 | 37 | 12 | int:DDX3X |
| Interaction | SMC5 interactions | RBM6 ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C HNRNPH3 DDX3X | 1.05e-09 | 1000 | 37 | 14 | int:SMC5 |
| Interaction | MIRLET7I interactions | 1.38e-09 | 114 | 37 | 7 | int:MIRLET7I | |
| Interaction | MIR9-3 interactions | 3.01e-09 | 70 | 37 | 6 | int:MIR9-3 | |
| Interaction | CAND1 interactions | DHX36 KRT9 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 HNRNPH3 DDX3X | 3.13e-09 | 894 | 37 | 13 | int:CAND1 |
| Interaction | MIR140 interactions | 3.29e-09 | 71 | 37 | 6 | int:MIR140 | |
| Interaction | CUL5 interactions | DHX36 KRT9 FAM98A TAF15 FUS ILF3 HNRNPUL1 RBM3 KRT77 HNRNPH3 DDX3X | 3.50e-09 | 567 | 37 | 11 | int:CUL5 |
| Interaction | DDX5 interactions | RBM6 DHX36 TCF4 ZNF326 TAF15 FUS ILF3 DDX17 HNRNPUL1 HNRNPH3 DDX3X | 3.56e-09 | 568 | 37 | 11 | int:DDX5 |
| Interaction | CUL4B interactions | TCF4 KRT9 TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C HNRNPH3 DDX3X | 3.64e-09 | 728 | 37 | 12 | int:CUL4B |
| Interaction | MIR18A interactions | 3.90e-09 | 73 | 37 | 6 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 3.90e-09 | 73 | 37 | 6 | int:MIR29B1 | |
| Interaction | MIR15A interactions | 4.60e-09 | 75 | 37 | 6 | int:MIR15A | |
| Interaction | MIR7-3 interactions | 4.98e-09 | 76 | 37 | 6 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 4.98e-09 | 76 | 37 | 6 | int:MIR16-1 | |
| Interaction | ILF2 interactions | DHX36 ZNF326 TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 DDX3X TLX2 | 5.29e-09 | 590 | 37 | 11 | int:ILF2 |
| Interaction | CUL2 interactions | KRT9 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 HNRNPH3 DDX3X | 5.38e-09 | 591 | 37 | 11 | int:CUL2 |
| Interaction | MIR9-2 interactions | 5.40e-09 | 77 | 37 | 6 | int:MIR9-2 | |
| Interaction | CHD3 interactions | KRT9 HIC1 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 PRRC2C KRT77 HNRNPH3 DDX3X | 5.65e-09 | 757 | 37 | 12 | int:CHD3 |
| Interaction | HNRNPA1 interactions | RBM6 DHX36 FRMD4A KRT9 ZNF326 TAF15 FUS ILF3 DDX17 HNRNPUL1 RBM3 HNRNPH3 DDX3X | 6.09e-09 | 945 | 37 | 13 | int:HNRNPA1 |
| Interaction | IL7R interactions | 6.10e-09 | 141 | 37 | 7 | int:IL7R | |
| Interaction | MIR222 interactions | 6.31e-09 | 79 | 37 | 6 | int:MIR222 | |
| Interaction | MIR206 interactions | 6.31e-09 | 79 | 37 | 6 | int:MIR206 | |
| Interaction | MIR34C interactions | 6.31e-09 | 79 | 37 | 6 | int:MIR34C | |
| Interaction | DAZL interactions | 7.42e-09 | 145 | 37 | 7 | int:DAZL | |
| Interaction | MIR10B interactions | 7.92e-09 | 82 | 37 | 6 | int:MIR10B | |
| Interaction | MIR31 interactions | 9.17e-09 | 84 | 37 | 6 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 9.17e-09 | 84 | 37 | 6 | int:MIR7-2 | |
| Interaction | MIR9-1 interactions | 9.85e-09 | 85 | 37 | 6 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 9.85e-09 | 85 | 37 | 6 | int:MIR16-2 | |
| Interaction | SNRNP70 interactions | DHX36 ZNF326 FAM98A TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 PRRC2C HNRNPH3 DDX3X | 9.89e-09 | 984 | 37 | 13 | int:SNRNP70 |
| Interaction | MIR141 interactions | 1.22e-08 | 88 | 37 | 6 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 1.22e-08 | 88 | 37 | 6 | int:MIR138-2 | |
| Interaction | MIR221 interactions | 1.39e-08 | 90 | 37 | 6 | int:MIR221 | |
| Interaction | MIR1-1 interactions | 1.39e-08 | 90 | 37 | 6 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 1.49e-08 | 91 | 37 | 6 | int:MIR200C | |
| Interaction | MATR3 interactions | RBM6 ZNF326 TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 HNRNPH3 DDX3X | 1.56e-08 | 655 | 37 | 11 | int:MATR3 |
| Interaction | MIR155 interactions | 1.59e-08 | 92 | 37 | 6 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 1.59e-08 | 92 | 37 | 6 | int:MIR128-1 | |
| Interaction | MIR205 interactions | 1.70e-08 | 93 | 37 | 6 | int:MIR205 | |
| Interaction | MIRLET7F1 interactions | 1.81e-08 | 94 | 37 | 6 | int:MIRLET7F1 | |
| Interaction | MIRLET7C interactions | 2.19e-08 | 97 | 37 | 6 | int:MIRLET7C | |
| Interaction | MIR363 interactions | 2.19e-08 | 97 | 37 | 6 | int:MIR363 | |
| Interaction | MIR106B interactions | 2.33e-08 | 98 | 37 | 6 | int:MIR106B | |
| Interaction | MIR19A interactions | 2.63e-08 | 100 | 37 | 6 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 2.80e-08 | 101 | 37 | 6 | int:MIRLET7B | |
| Interaction | ZC3H18 interactions | RBM6 ZNF326 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C HNRNPH3 | 2.90e-08 | 877 | 37 | 12 | int:ZC3H18 |
| Interaction | PRMT8 interactions | 3.33e-08 | 104 | 37 | 6 | int:PRMT8 | |
| Interaction | COPS5 interactions | DHX36 KRT9 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 RBM3 HNRNPH3 DDX3X | 3.79e-08 | 1102 | 37 | 13 | int:COPS5 |
| Interaction | YWHAH interactions | FRMD4A ZNF326 FAM98A IRS4 ILF3 HNRNPUL1 PUM1 TRIO EML3 PRRC2C KRT77 DDX3X TLX2 | 3.79e-08 | 1102 | 37 | 13 | int:YWHAH |
| Interaction | MIR34B interactions | 4.67e-08 | 110 | 37 | 6 | int:MIR34B | |
| Interaction | PHB1 interactions | DHX36 KRT9 FAM98A TAF15 IRS4 FUS ILF3 DDX17 HNRNPUL1 RBM3 PRRC2C HNRNPH3 DDX3X | 4.74e-08 | 1123 | 37 | 13 | int:PHB1 |
| Interaction | NFX1 interactions | 1.22e-07 | 466 | 37 | 9 | int:NFX1 | |
| Interaction | UFL1 interactions | DHX36 KRT9 ZNF326 FAM98A IRS4 FUS ILF3 DDX17 HNRNPUL1 PUM1 HNRNPH3 DDX3X | 1.70e-07 | 1031 | 37 | 12 | int:UFL1 |
| Interaction | FAM120A interactions | 1.86e-07 | 349 | 37 | 8 | int:FAM120A | |
| Interaction | RBM39 interactions | RBM6 DHX36 ZNF326 TAF15 FUS ILF3 DDX17 HNRNPUL1 PUM1 PRRC2C HNRNPH3 DDX3X | 1.91e-07 | 1042 | 37 | 12 | int:RBM39 |
| Interaction | RALY interactions | 2.16e-07 | 356 | 37 | 8 | int:RALY | |
| Interaction | HNRNPDL interactions | 2.56e-07 | 364 | 37 | 8 | int:HNRNPDL | |
| GeneFamily | RNA binding motif containing | 2.04e-05 | 213 | 29 | 5 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 5.12e-04 | 21 | 29 | 2 | 89 | |
| GeneFamily | DEAD-box helicases | 2.06e-03 | 42 | 29 | 2 | 499 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_SUBVENTRICULAR_ZONE | 2.48e-05 | 39 | 38 | 3 | MM441 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.57e-05 | 856 | 38 | 8 | M4500 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN | 5.22e-05 | 282 | 38 | 5 | M7623 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D4 | 6.63e-05 | 54 | 38 | 3 | M15468 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 7.77e-05 | 734 | 38 | 7 | M3835 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 9.68e-05 | 166 | 38 | 4 | M8129 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 5.30e-06 | 994 | 37 | 10 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#4 | 1.79e-05 | 90 | 37 | 4 | Facebase_RNAseq_e8.5_Floor Plate_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.09e-05 | 498 | 37 | 7 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 5.69e-05 | 395 | 37 | 6 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.92e-05 | 122 | 37 | 4 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 8.27e-05 | 843 | 37 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.49e-04 | 177 | 37 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 2.49e-04 | 989 | 37 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.89e-04 | 339 | 37 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-07 | 197 | 38 | 5 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.00e-07 | 198 | 38 | 5 | 7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.00e-07 | 198 | 38 | 5 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-07 | 199 | 38 | 5 | ce8dbfd969b3b9c08e1c57c2bfd899818e878731 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 7.36e-07 | 200 | 38 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 175 | 38 | 4 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 175 | 38 | 4 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-05 | 181 | 38 | 4 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-05 | 181 | 38 | 4 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-05 | 181 | 38 | 4 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 184 | 38 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-05 | 189 | 38 | 4 | 3f5522be3e24dcdb6272f18cee2f239dfdeff9ad | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 189 | 38 | 4 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 192 | 38 | 4 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-05 | 193 | 38 | 4 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 194 | 38 | 4 | 5bd0f739aa75f387cca7c3b2686493ee2d1ee968 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-05 | 195 | 38 | 4 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-05 | 195 | 38 | 4 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.30e-05 | 196 | 38 | 4 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 196 | 38 | 4 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | wk_08-11-Epithelial-PNS|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 197 | 38 | 4 | ce3f9feb6935f0e9daf13673b0a0d6e92817e187 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.34e-05 | 197 | 38 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 197 | 38 | 4 | 8951787ed1f7ac1772a6ef0ba2dd44c51fd3c47b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-05 | 197 | 38 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 197 | 38 | 4 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 197 | 38 | 4 | a07e1a9b95c9f8a09452cbfe5a9f06648f66e29e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 197 | 38 | 4 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 197 | 38 | 4 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 198 | 38 | 4 | 85881637641d8996be2edc65c4bceff0433135e7 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_CHODL+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.39e-05 | 198 | 38 | 4 | eb3c389e7452d74e5e15179503e480d6d11ca9ca | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.39e-05 | 198 | 38 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 198 | 38 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 198 | 38 | 4 | b58138581f1a9073267d64c1211c5b9b4de71d3e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 198 | 38 | 4 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | 646d6e84a2e70042ee5d68a045abb3fc6741fcc7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | b4824d3683a4e3025b8e74a0f1755b331b2a0ba7 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.48e-05 | 200 | 38 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.48e-05 | 200 | 38 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.48e-05 | 200 | 38 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.48e-05 | 200 | 38 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-04 | 108 | 38 | 3 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 130 | 38 | 3 | c70fb77324916d220d842a575558a8245c276599 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.11e-04 | 136 | 38 | 3 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.11e-04 | 136 | 38 | 3 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.44e-04 | 143 | 38 | 3 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.50e-04 | 144 | 38 | 3 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | MS-CD8-memory_CD4|MS / Condition, Cell_class and T cell subcluster | 3.04e-04 | 154 | 38 | 3 | aec893cf3e1cf90e18a9117183fc7a1f397425a9 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 156 | 38 | 3 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.34e-04 | 159 | 38 | 3 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.34e-04 | 159 | 38 | 3 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-04 | 161 | 38 | 3 | 63f0b97c741b610c450f65fa5764d712bfe09ce8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 161 | 38 | 3 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-04 | 164 | 38 | 3 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 3.65e-04 | 164 | 38 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-04 | 165 | 38 | 3 | 7978eefcfc40175e933f7a8b64a5dd1c661dd1ac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-04 | 167 | 38 | 3 | 5c0ede7783403f1c8004cf8c45785687e89046c6 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 3.99e-04 | 169 | 38 | 3 | 3d48acea7482bbe5bb9da4c3af5f9b0c9800122f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-04 | 172 | 38 | 3 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 4.20e-04 | 172 | 38 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-04 | 172 | 38 | 3 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-04 | 173 | 38 | 3 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.41e-04 | 175 | 38 | 3 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.41e-04 | 175 | 38 | 3 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.41e-04 | 175 | 38 | 3 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-04 | 176 | 38 | 3 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 177 | 38 | 3 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 177 | 38 | 3 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.64e-04 | 178 | 38 | 3 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.64e-04 | 178 | 38 | 3 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | C_00|World / shred on cell type and cluster | 4.72e-04 | 179 | 38 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.72e-04 | 179 | 38 | 3 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.72e-04 | 179 | 38 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-04 | 180 | 38 | 3 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.79e-04 | 180 | 38 | 3 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-04 | 180 | 38 | 3 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.95e-04 | 182 | 38 | 3 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-04 | 182 | 38 | 3 | f549b986caebc5eb1b2d12f34fe33087e8324a31 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 4.95e-04 | 182 | 38 | 3 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.03e-04 | 183 | 38 | 3 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-04 | 183 | 38 | 3 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 5.03e-04 | 183 | 38 | 3 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-04 | 183 | 38 | 3 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-04 | 185 | 38 | 3 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 5.19e-04 | 185 | 38 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-04 | 185 | 38 | 3 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-04 | 185 | 38 | 3 | 94d0f283d63d932f310cc5a17ea893d71ba60f5e | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.27e-04 | 186 | 38 | 3 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.36e-04 | 187 | 38 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 5.44e-04 | 188 | 38 | 3 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.44e-04 | 188 | 38 | 3 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.44e-04 | 188 | 38 | 3 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-04 | 189 | 38 | 3 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.52e-04 | 189 | 38 | 3 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-04 | 189 | 38 | 3 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-04 | 191 | 38 | 3 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 191 | 38 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-04 | 191 | 38 | 3 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| Computational | Genes in the cancer module 192. | 1.30e-05 | 112 | 30 | 5 | MODULE_192 | |
| Computational | Neighborhood of TERF1 | 3.34e-05 | 67 | 30 | 4 | MORF_TERF1 | |
| Computational | Genes in the cancer module 279. | 3.96e-05 | 141 | 30 | 5 | MODULE_279 | |
| Computational | Transcription. | 1.37e-04 | 96 | 30 | 4 | MODULE_124 | |
| Computational | Neighborhood of ACP1 | 2.65e-04 | 211 | 30 | 5 | MORF_ACP1 | |
| Computational | Neighborhood of UBE2I | 4.62e-04 | 238 | 30 | 5 | MORF_UBE2I | |
| Computational | Neighborhood of DEK | 7.41e-04 | 264 | 30 | 5 | MORF_DEK | |
| Computational | RNA splicing. | 7.63e-04 | 65 | 30 | 3 | MODULE_183 | |
| Computational | Genes in the cancer module 334. | 1.10e-03 | 166 | 30 | 4 | MODULE_334 | |
| Computational | Genes in the cancer module 198. | 1.37e-03 | 303 | 30 | 5 | MODULE_198 | |
| Computational | Neighborhood of UBE2N | 2.28e-03 | 95 | 30 | 3 | MORF_UBE2N | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.99e-07 | 178 | 37 | 6 | 3998_DN | |
| Drug | 5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA | 7.45e-07 | 198 | 37 | 6 | 908_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.22e-05 | 186 | 37 | 5 | 2353_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.49e-05 | 194 | 37 | 5 | 4263_DN | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 1.49e-05 | 194 | 37 | 5 | 3556_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.53e-05 | 195 | 37 | 5 | 6159_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.60e-05 | 197 | 37 | 5 | 164_DN | |
| Drug | genistein; Down 200; 10uM; PC3; HG-U133A | 1.60e-05 | 197 | 37 | 5 | 703_DN | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; PC3; HT_HG-U133A | 1.64e-05 | 198 | 37 | 5 | 3757_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; HL60; HT_HG-U133A | 1.64e-05 | 198 | 37 | 5 | 1838_DN | |
| Drug | bromovanin | 5.29e-05 | 127 | 37 | 4 | ctd:C515564 | |
| Drug | Nor 3 | 7.35e-05 | 50 | 37 | 3 | CID009578441 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.67e-04 | 171 | 37 | 4 | 7535_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.99e-04 | 179 | 37 | 4 | 4585_DN | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.31e-04 | 186 | 37 | 4 | 3178_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.35e-04 | 187 | 37 | 4 | 4302_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.40e-04 | 188 | 37 | 4 | 4835_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.45e-04 | 189 | 37 | 4 | 6750_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.45e-04 | 189 | 37 | 4 | 1045_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.45e-04 | 189 | 37 | 4 | 4271_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 2.45e-04 | 189 | 37 | 4 | 1288_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.50e-04 | 190 | 37 | 4 | 6718_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.55e-04 | 191 | 37 | 4 | 4303_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 2.55e-04 | 191 | 37 | 4 | 4647_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.55e-04 | 191 | 37 | 4 | 6236_UP | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.60e-04 | 192 | 37 | 4 | 6573_UP | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 4978_UP | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 6716_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 6699_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HT_HG-U133A | 2.71e-04 | 194 | 37 | 4 | 6705_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.71e-04 | 194 | 37 | 4 | 3779_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 2308_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 2621_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 2622_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 4508_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 6559_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; HL60; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 3025_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 3789_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A | 2.82e-04 | 196 | 37 | 4 | 1423_DN | |
| Drug | 5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA | 2.82e-04 | 196 | 37 | 4 | 960_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 1809_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 4438_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 3748_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 2547_DN | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 2638_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 2704_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 1314_DN | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 5097_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 1217_UP | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 6310_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 7037_DN | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 1855_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 4266_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 4966_DN | |
| Drug | cyclosporine A; Down 200; 1uM; MCF7; HG-U133A | 2.93e-04 | 198 | 37 | 4 | 602_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; HL60; HG-U133A | 2.98e-04 | 199 | 37 | 4 | 2039_UP | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; HL60; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 2921_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 5843_DN | |
| Drug | bis(2-chloroethoxy)methane | 3.04e-04 | 16 | 37 | 2 | ctd:C495703 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HG-U133A | 3.04e-04 | 200 | 37 | 4 | 1920_DN | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 4.34e-06 | 3 | 36 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 9.48e-05 | 12 | 36 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.01e-04 | 93 | 36 | 3 | C1535926 | |
| Disease | albuminuria | 2.07e-04 | 94 | 36 | 3 | EFO_0004285 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 6.16e-04 | 30 | 36 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | self rated health | 6.58e-04 | 31 | 36 | 2 | EFO_0004778 | |
| Disease | presubiculum volume | 6.58e-04 | 31 | 36 | 2 | EFO_0009400 | |
| Disease | osteoarthritis, knee | 9.45e-04 | 158 | 36 | 3 | EFO_0004616 | |
| Disease | hepatocyte growth factor-like protein measurement | 9.90e-04 | 38 | 36 | 2 | EFO_0008154 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 1.04e-03 | 39 | 36 | 2 | EFO_0008298 | |
| Disease | urinary albumin to creatinine ratio | 1.35e-03 | 179 | 36 | 3 | EFO_0007778 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.37e-03 | 398 | 36 | 4 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Heart Diseases | 1.45e-03 | 46 | 36 | 2 | C0018799 | |
| Disease | Malignant neoplasm of breast | 1.75e-03 | 1074 | 36 | 6 | C0006142 | |
| Disease | Intellectual Disability | 2.09e-03 | 447 | 36 | 4 | C3714756 | |
| Disease | Amyotrophic Lateral Sclerosis | 2.29e-03 | 58 | 36 | 2 | C0002736 | |
| Disease | Seizures | 2.37e-03 | 218 | 36 | 3 | C0036572 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDTGHRRGGGGGAGF | 141 | P60323 | |
| FEGRSSGPHGGGGQY | 236 | A0A2R8Y4L2 | |
| GEDNRGYGGSQGGGR | 171 | Q92804 | |
| QGGGRGRGGYDKDGR | 181 | Q92804 | |
| DRSGGGYGGDRSSGG | 421 | Q92804 | |
| RSRGGYGGDRGGGSG | 526 | Q92804 | |
| GGGFGAHGRGRSYSR | 91 | P98179 | |
| SRSGGGGHGSSRGFG | 621 | O00571 | |
| YGQCEGEGTRGGSGH | 166 | Q96HD1 | |
| REGRGQEYFHPGGGS | 86 | P13378 | |
| SGYGGGSSRVCGRGG | 51 | P35527 | |
| GGRGGSGGSYGRGSR | 476 | P35527 | |
| GGKGGGGSARYNQGR | 536 | Q8N158 | |
| RHGKYCHLRGGGGGG | 151 | Q14526 | |
| GSHMGGNYGDDRRGG | 461 | P35637 | |
| GNYGDDRRGGRGGYD | 466 | P35637 | |
| HNGAMGGLGSGYGTG | 426 | P15884 | |
| NSMDQYGGRHGSGGG | 2106 | Q9UPA5 | |
| YGGRHGSGGGGPDLV | 2111 | Q9UPA5 | |
| GGGGGGGGATYVFRV | 206 | P29376 | |
| ACTAGGGGGGYRGGD | 321 | P29376 | |
| GHGGAGGTDRGAQHR | 126 | A8MZ36 | |
| GGGGGGFHARLVHQG | 106 | Q03052 | |
| RDGRGMGGHGYGGAG | 171 | P31942 | |
| QRQHGEQLGGGGSGG | 86 | Q14671 | |
| GGAGGAGGGVYLHSQ | 811 | Q9P2Q2 | |
| GGAGGAGLHFAGHRR | 1306 | O95996 | |
| RSSGGGYGGGPAGGH | 16 | Q9H2U1 | |
| RGRGRGFGGANHGGY | 651 | Q12906 | |
| GGPGGGGQRHYRGHT | 291 | Q32P44 | |
| GGGGGGGGRSRYRTT | 556 | Q92841 | |
| RDENGGGAGGSGSHG | 21 | Q13115 | |
| GGGNYRGGFNRSGGG | 651 | Q9BUJ2 | |
| SRDGQGTAGGHGSGG | 546 | O14654 | |
| EEGGGRGEGGAYHHR | 96 | Q96EX2 | |
| GARDGPHGDYRGGEG | 76 | P78332 | |
| GFGGYREAGGQGGGA | 151 | Q14934 | |
| QQTGGRGGGRGGYEH | 331 | Q8NCA5 | |
| RGGGRGGYEHSSYGG | 336 | Q8NCA5 | |
| GGYEHSSYGGRGGHE | 341 | Q8NCA5 | |
| SSYGGRGGHEQGGGR | 346 | Q8NCA5 | |
| YDHGGRGGGRGNKHQ | 366 | Q8NCA5 | |
| PGGYHGGHSSGGYQG | 406 | Q8NCA5 | |
| NRYQDGGHHGDRGGG | 446 | Q8NCA5 | |
| GGGGGRLGHGRARYD | 36 | Q9UPR0 | |
| RGSYGGRGRGGRGHT | 1201 | Q9Y520 | |
| REYRTLGGGGGGGSG | 26 | Q9C0H9 | |
| YQRNHSGGGGGGGSG | 2286 | O75962 | |
| GLGRGGQGHGENGAF | 36 | O43763 | |
| SYGMDNHSGGGGGSR | 56 | Q5BKZ1 | |
| NHSGGGGGSRFGPYE | 61 | Q5BKZ1 | |
| GGGYGIHGRGFGSRS | 46 | Q7Z794 |